Company Sector

Large Molecule Drugs

Large Molecule Drugs groups companies developing biologics such as antibodies, peptides, nucleic acid therapies, and recombinant proteins. It is a broad category that captures many of the most important platform types in modern biotech.

Why watch Large Molecule Drugs

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Large Molecule Drugs news

The latest feed items from companies currently grouped under Large Molecule Drugs.

01
2026-08-13 05:00 EST
PHARPharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older
Source: Pharming Group
02
2026-08-04 06:00 EST
PHARPharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
Source: Pharming Group
03
2026-07-30 05:00 EST
PHARPharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
Source: Pharming Group
04
2026-07-16 06:00 EST
PHARPharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
Source: Pharming Group
05
2026-06-04 05:00 EST
PHARPharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
Source: Pharming Group
06
2026-06-02 06:00 EST
PHARPharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
Source: Pharming Group
07
2026-05-28 14:40 EST
PHARPharming Group announces results of 2026 Annual General Meeting of Shareholders
Source: Pharming Group
08
2026-05-22 19:30 EST
PHAREuropean Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
Source: Pharming Group
09
2026-05-07 05:05 EST
PHARPharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
Source: Pharming Group
10
2026-05-07 05:00 EST
PHARPharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026
Source: Pharming Group
11
2026-04-23 06:00 EST
PHARPharming Group to report first quarter 2026 financial results and provide business update on May 7
Source: Pharming Group
12
2026-04-16 06:00 EST
PHARPharming Group announces the 2026 Annual General Meeting of Shareholders
Source: Pharming Group
13
2026-04-07 06:00 EST
PHARPharming Group to participate in April investor conferences
Source: Pharming Group
14
2026-04-02 05:00 EST
PHARPharming Group announces the filing of its 2025 Annual Report and Form 20-F
Source: Pharming Group
15
2026-03-27 06:00 EST
PHARPharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
Source: Pharming Group
16
2026-03-24 06:00 EST
PHARPharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
Source: Pharming Group
17
2026-03-12 06:00 EST
PHARPharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow
Source: Pharming Group
18
2026-02-26 07:00 EST
PHARPharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
Source: Pharming Group
19
2026-02-17 07:00 EST
PHARPharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Source: Pharming Group
20
2026-02-03 06:00 EST
PHARPharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
Source: Pharming Group

View all latest news

Companies in Large Molecule Drugs

3 companies tagged with Large Molecule Drugs.

CAMX

Camurus

HNSA

Hansa Biopharma AB

PHAR

Pharming Group

Frequently Asked Questions

What does the Large Molecule Drugs sector include?

How many companies are currently tagged with Large Molecule Drugs?

3 companies are currently grouped under Large Molecule Drugs on BioPharmSignal.

Which companies are most visible in the Large Molecule Drugs group right now?

CAMX, HNSA, PHAR are among the companies currently shown on this sector page.

How can I watch news for Large Molecule Drugs?

Use the Watch button on this page to subscribe to Large Molecule Drugs headlines and related company updates through your BioPharmSignal saved filters.

What kinds of updates usually appear for Large Molecule Drugs?

The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Large Molecule Drugs.